ADVFN US – Market Content Editor

  • Donnelley Financial Solutions tops Q4 forecasts; shares little changed

    Donnelley Financial Solutions tops Q4 forecasts; shares little changed

    Donnelley Financial Solutions (NYSE:DFIN) on Tuesday delivered fourth-quarter results that comfortably beat Wall Street expectations, fueled by solid momentum in its software and technology-driven services businesses. Despite the earnings beat, DFIN shares were flat in pre-market trading following the release. The regulatory and financial compliance solutions provider reported adjusted earnings of $0.70 per share for…

  • Fiserv jumps 5% after report Jana Partners has taken stake and is advocating changes

    Fiserv jumps 5% after report Jana Partners has taken stake and is advocating changes

    Fiserv (NASDAQ:FISV) climbed 5% on Tuesday following a Wall Street Journal report that activist investor Jana Partners has accumulated a position in the payments and financial technology group and is pressing for strategic adjustments. According to the newspaper, Jana has been holding private talks with the Milwaukee-based company about initiatives aimed at boosting shareholder value.…

  • Genuine Parts drops more than 7% after Q4 earnings miss and softer 2026 outlook

    Genuine Parts drops more than 7% after Q4 earnings miss and softer 2026 outlook

    Genuine Parts Company (NYSE:GPC) on Tuesday posted fourth-quarter results that fell short of Wall Street forecasts and issued weaker-than-expected guidance for 2026, sending shares sharply lower in early trading. The automotive and industrial components distributor saw its stock slide 7.18% in pre-market dealings following the announcement. Adjusted earnings per share for the quarter came in…

  • Kennedy Wilson jumps after agreeing to $10.90-a-share buyout

    Kennedy Wilson jumps after agreeing to $10.90-a-share buyout

    Kennedy Wilson (NYSE:KW) surged 9% after announcing it had reached a definitive agreement to be taken private in an all-cash deal at a substantial premium to its prior closing price. The real estate investment manager said it will be acquired for $10.90 per share in cash by a consortium led by Chairman and CEO William…

  • Krystal Biotech slips more than 2% even after Q4 earnings and revenue top estimates

    Krystal Biotech slips more than 2% even after Q4 earnings and revenue top estimates

    Krystal Biotech Inc (NASDAQ:KRYS) on Tuesday delivered fourth-quarter results that came in ahead of Wall Street forecasts, though its shares moved lower in early trading. The stock declined 2.33% in pre-market activity despite the earnings beat. The gene therapy specialist reported adjusted earnings per share of $1.70, surpassing analyst expectations of $1.58 by $0.12. Quarterly…

  • Somnigroup International posts in-line Q4 earnings, sales trail forecasts

    Somnigroup International posts in-line Q4 earnings, sales trail forecasts

    Somnigroup International Inc (NYSE:SGI) on Tuesday delivered fourth-quarter adjusted earnings that met analyst projections, though revenue came in below market expectations. Shares of the mattress maker declined 0.99% in pre-market trading following the release. The company reported adjusted earnings per share of $0.72 for the quarter, matching Wall Street estimates. Revenue totaled $1.87 billion, missing…

  • USA Compression Partners reports softer Q4 profit, earnings miss despite record revenue

    USA Compression Partners reports softer Q4 profit, earnings miss despite record revenue

    USA Compression Partners LP (NYSE:USAC) on Tuesday posted fourth-quarter 2025 results that came in below analyst forecasts on the bottom line, even as the partnership delivered the highest quarterly revenue in its history. Shares of the natural gas compression services provider gained 1.50% in pre-market trading following the announcement. Net income for the quarter totaled…

  • Ocular Therapeutix plunges 35% despite positive wet AMD Phase 3 data

    Ocular Therapeutix plunges 35% despite positive wet AMD Phase 3 data

    Ocular Therapeutix Inc. (NASDAQ:OCUL) shares dropped 35% on Tuesday even after the company announced favorable results from its Phase 3 superiority study of AXPAXLI in patients with wet age-related macular degeneration (wet AMD). The biotech group said AXPAXLI achieved the primary endpoint in the SOL-1 trial, showing superiority over aflibercept in preserving vision at Week…

  • General Mills slides after trimming fiscal 2026 guidance

    General Mills slides after trimming fiscal 2026 guidance

    General Mills (NYSE:GIS) shares dropped 3.6% on Tuesday morning after the packaged food company lowered its outlook for fiscal 2026, pointing to a tougher consumer backdrop. The Minneapolis-based group, whose portfolio includes brands such as Cheerios and Betty Crocker, now expects organic net sales to decline between 1.5% and 2% in fiscal 2026. That compares…

  • Shutterstock tops Q4 profit forecasts despite sharp revenue drop

    Shutterstock tops Q4 profit forecasts despite sharp revenue drop

    Shutterstock Inc. (NYSE:SSTK) reported fourth-quarter adjusted earnings above expectations on Tuesday, even as revenue declined significantly amid continued pressure in its core content operations. Shares were little changed in pre-market trading following the release. The digital content provider delivered adjusted earnings per share of $0.67 for the quarter, ahead of the $0.51 consensus estimate. Revenue,…